A number of companies are in the preclinical phase of exosome
therapy research.
In Korea, Ilias and ExoCoBio are developing exosome therapeutics.
Ilias – founded by faculty from the Korean Advance Institute of
Science and Technology – specialises in loading large protein
therapeutics into exosomes.
It is currently carrying out preclinical research toward treating
sepsis, preterm labour and Gaucher’s disease. ExoCoBio is focusing
on the native regenerative capacity of exosomes derived from
mesenchymal stem cells, including to treat atopic dermatitis.
<Born2Invest> 2020. 2. 9